Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction

Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study ID
NCT07084519
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • hypofractionated radiotherapy — RADIATION
    43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks)
  • conventional fractionated radiotherapy — RADIATION
    50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks

Study Details

This study investigates the safety and efficacy of hypofractionated radiotherapy (HFRT) versus conventional fractionated radiotherapy (CFRT) in breast cancer patients undergoing total mastectomy with prosthetic reconstruction. Study Design Population: Patients with high-risk breast cancer after mastectomy and immediate implant reconstruction. Intervention: HFRT Arm: 43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks). Control Arm: CFRT (50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks). Endpoints Primary: Reconstruction failure rate (e.g., implant removal, capsular contracture)

Key Dates

Start date
Aug 10, 2025
Status verified
Jun 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2030

Study Design

Enrollment
190 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: HFRT group
    43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks)
  • Other: CFRT group
    50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks

Primary Outcome Measure

Reconstruction Failure Rate [ Time Frame: 2 year ]

Central Contacts

Related Studies